Glucagon-like peptide receptor agonists (GLP-1RAs) as cardiovascular risk modifiers in obstructive sleep apnea and obesity: a real-world study

Journal of Clinical Sleep Medicine · Published 2026-07-01 · DOI 10.1007/s44470-026-00110-x

Free full text

Authors (7)

Jaeun Ahn, Junmin Song, Kyle Admire, Yu Chang, Kuan-Yu Chi, Nathaniel T. Gordon, Joshua M. Sill

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ahn, J., Song, J., Admire, K., et al. (2026). Glucagon-like peptide receptor agonists (GLP-1RAs) as cardiovascular risk modifiers in obstructive sleep apnea and obesity: a real-world study. Journal of Clinical Sleep Medicine. https://doi.org/10.1007/s44470-026-00110-x

Related articles